Lisata Therapeutics (LSTA) Competitors

Lisata Therapeutics logo
$2.52 +0.01 (+0.40%)
Closing price 02/12/2025 04:00 PM Eastern
Extended Trading
$2.57 +0.05 (+1.98%)
As of 02/12/2025 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LSTA vs. ALTS, IGMS, DBVT, ADAG, AVTX, TNYA, PWUP, ALGS, VTGN, and ZIVO

Should you be buying Lisata Therapeutics stock or one of its competitors? The main competitors of Lisata Therapeutics include Janone (ALTS), IGM Biosciences (IGMS), DBV Technologies (DBVT), Adagene (ADAG), Avalo Therapeutics (AVTX), Tenaya Therapeutics (TNYA), PowerUp Acquisition (PWUP), Aligos Therapeutics (ALGS), Vistagen Therapeutics (VTGN), and ZIVO Bioscience (ZIVO). These companies are all part of the "pharmaceutical products" industry.

Lisata Therapeutics vs.

Lisata Therapeutics (NASDAQ:LSTA) and Janone (NASDAQ:ALTS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, community ranking, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

Lisata Therapeutics' return on equity of -51.19% beat Janone's return on equity.

Company Net Margins Return on Equity Return on Assets
Lisata TherapeuticsN/A -51.19% -45.16%
Janone N/A -2,940.01%-39.81%

Lisata Therapeutics received 14 more outperform votes than Janone when rated by MarketBeat users.

CompanyUnderperformOutperform
Lisata TherapeuticsOutperform Votes
14
93.33%
Underperform Votes
1
6.67%
JanoneN/AN/A

Janone has higher revenue and earnings than Lisata Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lisata TherapeuticsN/AN/A-$20.84M-$2.51-1.00
Janone$39.61M2.17-$7.81MN/AN/A

Lisata Therapeutics has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Comparatively, Janone has a beta of 1.89, indicating that its stock price is 89% more volatile than the S&P 500.

In the previous week, Lisata Therapeutics had 1 more articles in the media than Janone. MarketBeat recorded 1 mentions for Lisata Therapeutics and 0 mentions for Janone. Janone's average media sentiment score of 1.89 beat Lisata Therapeutics' score of 0.96 indicating that Janone is being referred to more favorably in the news media.

Company Overall Sentiment
Lisata Therapeutics Positive
Janone Very Positive

8.9% of Lisata Therapeutics shares are owned by institutional investors. Comparatively, 6.3% of Janone shares are owned by institutional investors. 9.1% of Lisata Therapeutics shares are owned by company insiders. Comparatively, 4.9% of Janone shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Lisata Therapeutics presently has a consensus target price of $15.00, indicating a potential upside of 495.24%. Given Lisata Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Lisata Therapeutics is more favorable than Janone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lisata Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Janone
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Lisata Therapeutics beats Janone on 8 of the 13 factors compared between the two stocks.

Get Lisata Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LSTA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LSTA vs. The Competition

MetricLisata TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$21.14M$6.88B$5.65B$9.04B
Dividend YieldN/A2.90%5.31%4.00%
P/E Ratio-1.009.6390.3919.28
Price / SalesN/A312.201,034.9479.82
Price / CashN/A75.4646.0938.87
Price / Book0.435.535.135.00
Net Income-$20.84M$123.50M$113.24M$222.75M
7 Day Performance-4.55%-3.32%-0.65%-0.72%
1 Month Performance-31.34%-0.11%5.24%4.19%
1 Year Performance-8.70%5.39%25.17%21.73%

Lisata Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LSTA
Lisata Therapeutics
3.4306 of 5 stars
$2.52
+0.4%
$15.00
+495.2%
-7.4%$21.14MN/A-1.0030Short Interest ↓
ALTS
Janone
N/A$6.05
-8.3%
N/AN/A$85.12M$39.61M0.00170Positive News
IGMS
IGM Biosciences
4.8242 of 5 stars
$1.43
-5.3%
$5.50
+284.6%
-92.0%$85.03M$2.92M-0.39190
DBVT
DBV Technologies
3.8493 of 5 stars
$4.13
-2.5%
$22.50
+445.5%
-53.4%$84.85M$15.73M-0.9280Analyst Forecast
Short Interest ↓
ADAG
Adagene
2.8598 of 5 stars
$1.90
+0.1%
$8.00
+320.8%
-51.1%$84.16M$18.11M0.00260Short Interest ↓
AVTX
Avalo Therapeutics
3.6935 of 5 stars
$8.02
-4.8%
$40.00
+398.8%
+58.7%$83.33M$1.92M0.0040Positive News
TNYA
Tenaya Therapeutics
3.2763 of 5 stars
$1.05
-0.9%
$17.33
+1,550.8%
-84.1%$83.18MN/A-0.73110
PWUP
PowerUp Acquisition
N/A$10.50
-18.9%
N/A+14.2%$81.59MN/A0.00N/ANews Coverage
Gap Up
ALGS
Aligos Therapeutics
4.4455 of 5 stars
$22.57
-12.5%
$75.00
+232.3%
+23.6%$81.03M$15.53M-1.6990Short Interest ↓
News Coverage
VTGN
Vistagen Therapeutics
1.0006 of 5 stars
$2.91
+0.7%
N/A-46.8%$81.01M$1.06M-2.3540News Coverage
ZIVO
ZIVO Bioscience
N/A$21.24
+7.3%
N/A+132.4%$78.80M$30,000.00-4.3510

Related Companies and Tools


This page (NASDAQ:LSTA) was last updated on 2/13/2025 by MarketBeat.com Staff
From Our Partners